Fig. 1.
GSPE improves pancreatic function and T2DM symptoms in diabetic rats. Confirmation of the establishment of the diabetes rat model at week 12, as shown by A fasting blood glucose levels, B body weight, C water intake, and D urine volume. E The hemoglobin A1c (HbA1c) level and F insulin level were assessed using ELISA and G analysis of homeostasis model assessment-insulin resistance (HOMA-IR) value. HOMA-IR was calculated by fasting insulin × fasting blood glucose/22.5), (H) HE staining of pancreatic islets in diabetic rats (× 400). Data are expressed as mean ± SD (*P < 0.05 vs. control; #P < 0.05 vs. T2DM)